Literature DB >> 18778785

Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro.

Guang-Zhen Jin1, Su-Jin Cho, Eu-Gene Choi, Young-S Lee, Xian-Feng Yu, Kap-Seong Choi, Sung-Tae Yee, Jin-Tae Jeon, Myeong-Ok Kim, Il-Keun Kong.   

Abstract

Mesenchymal stem cells (MSCs) are pluripotent adult stem cells. It has been shown that MSCs secrete neurotrophic factors involving nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). Also, these neurotrophic factors can upregulate tyrosine hydroxylase (TH) gene expression in PC12 cells and neural stem cells. Here, we investigated the effect of co-culturing rat E13.5 ventral mesencephalic cells (VMCs) with MSCs from rat bone marrow on TH expression and dopamine (DA) content. The study consisted of 3 groups: MSC, VMC and a combined MSC+VMC group. All groups were cultured in serum-free neuro-basal medium for 3 days. Thereafter, each group was analyzed by RT-PCR, western blotting, and HPLC. The co-culture group showed a higher expression at TH and DA than the VMC group. However, TH and DA were not present in the MSC group. These observations suggest that MSCs could be an alternative source for treating neurodegenerative diseases such as Parkinson's disease (PD).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778785     DOI: 10.1016/j.cellbi.2008.08.014

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  10 in total

Review 1.  Stem Cell Transplantation and Physical Exercise in Parkinson's Disease, a Literature Review of Human and Animal Studies.

Authors:  Jaison Daniel Cucarián Hurtado; Jenny Paola Berrío Sánchez; Ramiro Barcos Nunes; Alcyr Alves de Oliveira
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

Review 2.  Mesenchymal stem cells for the treatment of neurodegenerative disease.

Authors:  Nanette Joyce; Geralyn Annett; Louisa Wirthlin; Scott Olson; Gerhard Bauer; Jan A Nolta
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

3.  Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.

Authors:  Thomas V Johnson; Natalie D Bull; David P Hunt; Nephtali Marina; Stanislav I Tomarev; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

4.  Updates in the pathophysiological mechanisms of Parkinson's disease: Emerging role of bone marrow mesenchymal stem cells.

Authors:  Hanaa H Ahmed; Ahmed M Salem; Hazem M Atta; Emad F Eskandar; Abdel Razik H Farrag; Mohamed A Ghazy; Neveen A Salem; Hadeer A Aglan
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

5.  Therapeutic Potential of Magnetic Nanoparticle-Based Human Adipose-Derived Stem Cells in a Mouse Model of Parkinson's Disease.

Authors:  Ka Young Kim; Keun-A Chang
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

6.  Salidroside induces rat mesenchymal stem cells to differentiate into dopaminergic neurons.

Authors:  Hong-Bin Zhao; Hui Ma; Xiao-Qin Ha; Ping Zheng; Xiao-Yun Li; Ming Zhang; Ju-Zi Dong; Yin-Shu Yang
Journal:  Cell Biol Int       Date:  2014-01-31       Impact factor: 3.612

7.  Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study.

Authors:  Rosaria Giordano; Margherita Canesi; Maurizio Isalberti; Ioannis Ugo Isaias; Tiziana Montemurro; Mariele Viganò; Elisa Montelatici; Valentina Boldrin; Riccardo Benti; Agostino Cortelezzi; Nicola Fracchiolla; Lorenza Lazzari; Gianni Pezzoli
Journal:  J Transl Med       Date:  2014-01-17       Impact factor: 5.531

8.  Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson's disease.

Authors:  Erin F Wolff; Levent Mutlu; Efi E Massasa; John D Elsworth; D Eugene Redmond; Hugh S Taylor
Journal:  J Cell Mol Med       Date:  2014-10-06       Impact factor: 5.310

9.  Adipose-derived Stem Cells Stimulated with n-Butylidenephthalide Exhibit Therapeutic Effects in a Mouse Model of Parkinson's Disease.

Authors:  Kang Chi; Ru-Huei Fu; Yu-Chuen Huang; Shih-Yin Chen; Ching-Ju Hsu; Shinn-Zong Lin; Chi-Tang Tu; Li-Hsun Chang; Ping-An Wu; Shih-Ping Liu
Journal:  Cell Transplant       Date:  2018-05-14       Impact factor: 4.064

10.  Combination of butylphthalide with umbilical mesenchymal stem cells for the treatment of delayed encephalopathy after carbon monoxide poisoning.

Authors:  Huanjun Wang; Yan Li; Qiang Wu; Chenglong Xu; Qingran Liu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.